Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Penza State University
🇷🇺
Russia
Country
🇷🇺
Russia
Ownership
Private
Established
1943-01-01
Employees
1K
Market Cap
-
Website
https://pnzgu.ru
Clinical Trials
Related News
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
Not Applicable
Active, not recruiting
Conditions
STEMI
Covid19
NSTEMI
Interventions
Drug: Atorvastatin 80mg
Drug: Atorvastatin-Ezetimibe
Subscribe
First Posted Date
2021-05-25
Last Posted Date
2023-11-24
Lead Sponsor
Penza State University
Target Recruit Count
45
Registration Number
NCT04900155
Locations
🇷🇺
Valentin Oleynikov, Penza, Russian Federation
Subscribe
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
Phase 4
Recruiting
Conditions
Myocardial Strain
Arterial Stiffness
Myocardial Infarction, Acute
Quality of Life
Interventions
Drug: Atorvastatin 80mg
Subscribe
First Posted Date
2020-04-15
Last Posted Date
2023-11-24
Lead Sponsor
Penza State University
Target Recruit Count
300
Registration Number
NCT04347434
Locations
🇷🇺
Valentin Oleynikov, Penza, Russian Federation
Subscribe
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
Phase 4
Completed
Conditions
Myocardial Infarction
Interventions
Drug: Atorvastatin
Subscribe
First Posted Date
2015-10-29
Last Posted Date
2020-03-24
Lead Sponsor
Penza State University
Target Recruit Count
200
Registration Number
NCT02590653
Locations
🇷🇺
Valentin Oleynikov, Penza, Russian Federation
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy